Bristol-Myers Squibb (BMY) option implied volatility increases
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $48.99 -0.31%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 4.7%
Revenue Growth %: +1.4%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 4.7%
Revenue Growth %: +1.4%
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) March weekly call option implied volatility is at 29, April is at 34; compared to its 52-week range of 17 to 44 into the proposed acquisition of Celgene Corporation (CELG).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies
- CME Group (CME) April weekly option implied volatility into quarter results
- Apple (AAPL) option IV into events
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
